HDL proteomics: pot of gold or Pandora’s box?-Reference-Cited by-同舟云学术

HDL proteomics: pot of gold or Pandora’s box?

Published:2007-03-01 Issue:3 Volume:117 Page:595-598
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Reilly Muredach P.,Tall Alan R.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference31 articles.

1. Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes

2. FDA. 2006. Pfizer stops all torcetrapib clinical trials in interest of patient safety [press release]. http://www.fda.gov/bbs/topics/NEWS/2006/NEW01514.html.

3. Genetics of Increased HDL Cholesterol Levels

4. Hepatic high-density lipoprotein receptors: Roles in lipoprotein metabolism and potential for therapeutic modulation

5. Macrophage Reverse Cholesterol Transport

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of saturated fat intake from dairy on CVD markers: the role of food matrices;Proceedings of the Nutrition Society;2024-02-06

2. Targeted Measurements of O- and N-Glycopeptides Show That Proteins in High Density Lipoprotein Particles Are Enriched with Specific Glycosylation Compared to Plasma;Journal of Proteome Research;2017-12-27

3. Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology;Progress in Lipid Research;2014-10

4. Connective tissue and inflammation;Orvosi Hetilap;2014-03

5. Adsorption of plasma proteins on uncoated PLGA nanoparticles;European Journal of Pharmaceutics and Biopharmaceutics;2013-09